期刊文献+

神经母细胞瘤组织中TRAIL、Caspase-3的表达 被引量:2

Expression of TRAIL and Caspase-3 in neuroblastoma
下载PDF
导出
摘要 目的:检测神经母细胞瘤(NB)组织中TRAIL、Caspase-3的表达。方法:运用原位杂交、免疫组化及TUNEL法检测TRAIL、Caspase-3在26例NB、9例神经节细胞瘤和10例正常肾上腺组织中的表达及细胞凋亡。结果:①TRAIL、Caspase-3及凋亡指数(AI)在NB、神经节细胞瘤及正常组织中的表达差异无统计学意义(P均>0.05)。②NB中TRAIL的表达与年龄、性别、部位、组织类型、INSS分期等无关(P>0.05),Caspase-3、AI的表达与组织类型、临床分期、病理分型有关(P<0.05)。③3种组织中Caspase-3和AI呈正相关(在NB、神经节细胞瘤和正常肾上腺组织中r分别=0.888,0.989,0.958,P均=0.000);此外,在7例Caspase-3(+)表达的NB中,TRAIL和Caspase-3呈正相关(r=0.974,P=0.001)。结论:TRAIL通过激活Caspase-3可以显著诱导NB细胞凋亡,有助于抑制NB的生长。 Aim: To investigate the faction and clinic value of TRAIL and Caspase-3 in neuroblastoma. Methods: The in-situ hybrization technique, immunohistochemistory S-P method and TUNEL method were adopted for detection of expression of TRAIL mRNA, Caspase-3 protein and apoptotic cell. ReSUltS:①The expressions of TRAIL, Caspase-3 and apoptosis index indicated no statistical difference ( P > 0. 05 ) among neuroblastoma, ganglioneuroblastoma and normal ad-renmedullary tissue.②No difference of TRAIL expression was found in groups of neuroblastoma ( P>0.05) , but expression of Caspase-3 and apoptosis index were related with tissue type , clinical stage and histological classification. ( P < 0.05). ③No relationship was found between TRAIL and Caspase-3 in all of three kinds of tissues; but expression of TRAIL was irrelevant to expression of apoptosis index; and Caspase-3 and AI manifested positive relation ( r = 0. 888, 0.989,0.958, P =0.000). Moreover, TRAIL and Caspase-3 manifested positive relation in seven cases neuroblastoma of Caspase-3 ( + ) (r =0.974, P =0.001 ). Conclusion: TRAIL can markedly induce neuroblastoma cell apoptosis which primarily pass to activate Caspase-3 , and which is conductive to repress growth of neuroblastoma.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2004年第2期205-208,共4页 Journal of Zhengzhou University(Medical Sciences)
基金 河南省科技攻关基金资助项目 324410085
关键词 神经母细胞瘤 基因 细胞凋亡 原位杂交 免疫组织化学 neuroblastoma genes cell apoptosis in-situ hybrization immunohistochemistry
  • 相关文献

参考文献9

  • 1Srivastava RK. TRAIL/APO-2L: mechanisms and clinical applications in cancer. Neoplasia, 2001, 3 (6): 535.
  • 2Kawasaki H, Toyoda M, Shinohara H, et al. Expression of Survivin correlates with apoptosis, proliferation and angiogenesis during human colorectal tumorigenesis. Cancer,2001, 91(11) :2 026.
  • 3Yin XM, Wang K, Gross A, et al. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature,1999, 400(6 747): 886.
  • 4Velthuis JH, Rouschop KM, De Bont H J, et al. Distinct intracellular signaling in tumor necrosis factor-related apoptosis-inducing ligand-and CD95 ligand-mediated apoptosis. J Biol Chem, 2002, 277(27): 24 631.
  • 5Mlynarczuk I, Hoser G, Grzela T, et al. Augmented pro-apoptotic effects of TRAIL and proteasome inhibitor in human promonocytic leukemia U937 cells. Anticancer Res, 2001,21(2A): 1 237.
  • 6Eggert A, Grotzer MA, Zuzak TJ, et al. Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL induced apoptosis in neuroblastoma cells correlates with a loss of Caspase-8 expression. Cancer Res, 2001, 61 (4):1 314.
  • 7Koizumi H, Ohkawa I, Tsukahara T, et al. Apoptosis in favorable neuroblastoma is not dependent on Fas (CD95/APO-1 ) expression but on activated Caspase-3 (CPP32). J Pathol, 1999, 189(3): 410.
  • 8Posmantur R, McGinnis K, Nadimpalli R, et al. Characterization of CPP32-like protease activity following apoptotic challenge in SH-SY5Y neuroblastoma cells. J Neurochem,1997, 68(6): 2 328.
  • 9Hao C,Beguinot F,Condorelli G,et al. Induction and intracellular regulation of tumor necrosis factor-related apoptosis inducing ligand (TRAIL) mediated apoptosis in human malignant glioma cells. Cancer Res, 2001, 61 (3): 1 162.

同被引文献17

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部